Birzeit Pharmaceutical Company (BPC) was established in 1974. It'd successfully completed a number of amalgamations and had overcome challenges and development periods that led the business to secure a solid position Palestine, in its local marketplace, as well as introduce a wide array of products in the export market. BPC's constant success, despite political instability and continuous restrictions on its growth and expansion, led the business's vision to focus past the local existence. In spite of the development of BPC and its being financially sound, it was quite similar to other Arab companies, which were reluctant to invest massive levels of money in growing outside their regions, and take huge risks. BPC didn't want to risk large amounts of money to grow the business further, and instead chose to expand to new markets or introduce new market products on a conservative basis.
BPC needed the packaging company to later grow to a manufacturing company, and correspondingly to an export location. In a business environment that was based on selections that were rapid due to the fast growing businesses, high competition and emerging markets, the company needed to make quicker decisions, invest more money and select a new avenue to secure its business development and increase. Competition in pharmaceutical production and notably among generics was increasing and the faster BPC moved, the more competitive it would be.
PUBLICATION DATE: February 16, 2011 PRODUCT #: 910A27-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Schneider Building
Scranton Furniture Co.
Welsh Water (E): General Information and Confidential Instructions for Pat Cooper Lead Negotiator for NUPE
Wa Guanxi and Inhwa: Managerial Principles in Japan China and Korea
General Electric: Valley Forge (C)
Acme Hardware
Walmart around the World
Transitions Asia: Managing Across Cultures
Be Our Guest
Crisis and Reform in Japan’s Banking System (A)
